Last updated at 01 Jul 2024 10:40 AM
Director
DIN: 08188996
Vijaybhai Arjanbhai Nagecha is currently associated with 1 company in various capacities such as Individual Promoter and Director. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08188996.Vijaybhai Arjanbhai Nagecha has previously been associated with 1 company in roles such as Additional Director.Vijaybhai Arjanbhai Nagecha is currently involved in 2 different roles. Their most recent position is with ROSEFINCH PHARMACEUTIQUE PRIVATE LIMITED as a Individual Promoter. The first company Vijaybhai Arjanbhai Nagecha was appointed to as a director was ROSEFINCH PHARMACEUTIQUE PRIVATE LIMITED. Vijaybhai Arjanbhai Nagecha is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Vijaybhai Arjanbhai Nagecha is currently associated with 1 company in various capacities such as Individual Promoter and Director. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08188996.Vijaybhai Arjanbhai Nagecha has previously been associated with 1 company in roles such as Additional Director.Vijaybhai Arjanbhai Nagecha is currently involved in 2 different roles. Their most recent position is with ROSEFINCH PHARMACEUTIQUE PRIVATE LIMITED as a Individual Promoter. The first company Vijaybhai Arjanbhai Nagecha was appointed to as a director was ROSEFINCH PHARMACEUTIQUE PRIVATE LIMITED. Vijaybhai Arjanbhai Nagecha is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Male
India
Gain instant access to verified contact details.
Current Companies (1)
Current LLPs (0)
Past Companies (1)
1y 10m 11 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| ROSEFINCH PHARMACEUTIQUE PRIVATE LIMITED | Individual Promoter | 22-Dec-2016 |
| ROSEFINCH PHARMACEUTIQUE PRIVATE LIMITED | Director | 30-Sep-2022 |